Clinical Trial Update: Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients

View source ↗

Summary

A completed clinical trial evaluating whether SGLT-2 inhibitors influence atrial fibrillation recurrence in patients with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Diabetes Mellitus

Drugs mentioned

• SGLT-2 inhibitors

Snippet

Sponsor: Bursa Postgraduate Hospital | Conditions: Diabetes Mellitus, Atrial Fibrillation (AF) | Status: COMPLETED